Visiongain Publishes Medical Imaging Phantoms Market Report 2020-2030

22 July 2020

Visiongain has launched a new report Medical Imaging Phantoms Market Report 2020-2030: Forecast by Type (X-ray Phantoms, Ultrasound Phantoms, CT Phantoms, MRI Phantoms, Nuclear Imaging Phantoms and Others), by Material (Simulating Devices, and False Organs), by End-user (Hospitals, Academic & Research Institutes, Diagnostic & Reference Laboratories, and Medical Device Companies), and by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.

In the biomedical research, medical imaging phantoms are objects used as stand-ins for human tissues to guarantee that systems and methods for imaging the human body are functioning appropriately. Imaging phantoms helps to ensure that medical images provide reliable and quantitative information. It provide the confidence needed to compare images taken on different scanning machines, or on the same machine at different times and thus can be used to calibrate or compare to standard scales.

According to the Medicare Payment Advisory Commission (MedPAC) and the Centers for Medicare and Medicaid Services (CMS), the rise in volume of imaging services per Medicare beneficiary exceeded the growth of all other services physicians provide. Incidence of chronic deceases such as cancer, cardiac ailments and other deceases are rising globally due the factors such as ageing population, inadequate nutrition, elevated stress level, and sedentary life style. Also, according to data from World Population Prospects, by 2050, one in six people in the world will be over age 65 (16%). These factors has led to increased demand for early-stage diagnosis of chronic and other disease resulting into largescale application of medical imaging. Imaging phantoms help in enhancing the efficiency of imaging devices by helping medical experts in detecting, interpreting, analysing, and evaluating information required for treatments thereby driving the growth of medical imaging phantoms market.

The Visiongain report analyst commented “that the ongoing COVID-19 pandemic provides a strong depiction of the positive growth rate that will be experienced by the medical imaging phantoms market during the forecast period. The Coronavirus outbreak has urged researchers and doctors to execute their duties at an accelerated pace. Hence, to enable this, medical imaging phantoms would prove to be of boundless use. A rise in the research numbers as well as COVID-19 screenings to find coronavirus positive patients may serve as growth boosters for the medical imaging phantoms market.”

Realistic medical imaging phantoms of organs and tissues are being developed using 3D technology to enhance the performance of medical imaging devices. This, in turn, is expected to drive the medical imaging phantom market growth over the forecast period. Moreover, increasing number of preclinical studies to understand the effectiveness of these phantoms for hybrid imaging devices is expected to expand the growth potential in the coming years.

The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include Gold Standard Phantoms, PTW Freiburg GmbH, Kyoto Kagaku Co. Ltd., Dielectric Corporation, Pure Imaging Phantoms, Leeds Test Objects Ltd, Modus Medical Devices Inc., Computerized Imaging Reference Systems, Inc. (CIRS, A Castleray), Carville Limited, and Biodex Medical Systems, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on

Recent News

Visiongain Publishes European Antibiotics Market Report 2021-2031

Penicillin segment holds majority of the market share owing to maximum prescription as well as the most generic manufacturers throughout the industry.

22 June 2021


Visiongain Publishes Companion Diagnostics (CDx) Market Report 2021-2031

Over the last few years, companion diagnostics has gained widespread attention due to the technological advancements, growing demand for precision medicine, and accelerating demand for targeted therapy.

17 June 2021


Visiongain Publishes Cellular Immunotherapy Market Report 2021-2031

Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.

15 June 2021


Visiongain Publishes Gene Therapy R&D Market Report 2021-2031

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

14 June 2021